Top Trends Transforming the Hemato Oncology Testing Market Landscape in 2025: NeoGenomics Launches AML Express for Enhanced AML Detection and Treatment

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Hemato Oncology Testing Industry Market Size Be by 2025?
There has been a swift expansion in the hemato oncology testing market in the past few years. The market, which was valued at $3.5 billion in 2024, is predicted to surge to $3.96 billion in 2025, reflecting a compound annual growth rate (CAGR) of 13.3%. Factors contributing to this growth during the historic period include a rise in cancer cases, heightened awareness and screening initiatives, elevated healthcare spending, a growing trend towards personalized medicine, and a surge in the occurrence of blood disorders.

What's the Long-Term Growth Forecast for the Hemato Oncology Testing Market Size Through 2029?
The market size for hemato oncology testing is projected to witness substantial expansion in the forthcoming years, escalating to "$6.83 billion by 2029 with a compound annual growth rate (CAGR) of 14.6%. The surge during the forecast period can be explained by the popularity of personalized medicine, incorporation of artificial intelligence, an increasing aged population, enhancements in genomic studies, and a growing appeal for early cancer detection. Main points of interest in the forecast period involve technological progress in genomic testing, non-invasive liquid biopsy testing, industry collaborations and partnerships, regulatory landscape and standardization, and additional technological innovations.

View the full report here:
https://www.thebusinessresearchcompany.com/report/hemato-oncology-testing-global-market-report

What Are the Key Growth Drivers Fueling the Hemato Oncology Testing Market Expansion?
The hemato oncology testing market is predicted to expand in response to the growing number of hematologic cancer cases. Hematologic cancers are a group of diseases that begin in the blood and impact the blood, bone marrow, and lymphatic system. This group includes conditions such as leukemia, lymphoma, and myeloma. Early diagnosis, made possible through hemato oncology testing, can lessen the impact of these diseases. As an illustration, the American Cancer Society, a voluntary health organization targeting cancer eradication in the US, expects leukemia to affect 59,610 Americans and result in 23,710 deaths in 2023. In addition, new cases of non-Hodgkin lymphoma are projected to touch 80,550 people in the US, leading to 20,180 deaths. Consequently, the rising occurrences of hematologic cancers are fueling the growth of the hemato oncology market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10075&type=smp

What Are the Key Trends Driving Hemato Oncology Testing Market Growth?
Next-generation sequencing is transforming the hemato-oncology testing market. In October 2024, US-based NeoGenomics Inc. launched AML Express, an NGS platform for detecting mutations in Acute Myeloid Leukemia. This tool offers fast, accurate results to support timely and targeted cancer treatment decisions.

How Is the Hemato Oncology Testing Market Segmented?
The hemato oncology testing market covered in this report is segmented -

1) By Product And Services: Assay Kits And Reagents, Services
2) By Cancer Type: Leukemia, Lymphoma, Multiple Myeloma, Other Cancers
3) By Technology: Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), Next-Generation Sequencing (NGS), Other Technologies
4) By End User: Hospitals, Academic And Research Institutes, Other End Users

Subsegments:
1) By Assay Kits And Reagents: PCR Kits, Next-Generation Sequencing (NGS) Kits, Flow Cytometry Reagents, ELISA Kits, Antibodies
2) By Services: Testing Services, Consultation Services, Data Analysis Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10075&type=smp

Which Companies Are Leading the Charge in Hemato Oncology Testing Market Innovation?
Major companies operating in the hemato oncology testing market include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Illumina Inc., Invivoscribe Inc., Qiagen N.V., Bio-Rad Laboratories Inc., Archerdx Inc., ARUP Laboratories Inc., Asuragen Inc., Adaptive Biotechnologies Corp., Cepheid Inc., EntroGen Inc., CORE Diagnostics Inc., Genoptix Inc., GenPath Diagnostics, NeoGenomics Laboratories Inc., Siemens AG, Sysmex Corporation, Laboratory Corporation of America Holdings, Agilent Technologies, Danaher Corporation, Grifols SA, Diaorin SpA, HTG Molecular Diagnostics Inc., Admera Health

Which Regions Are Leading the Global Hemato Oncology Testing Market in Revenue?
North America was the largest region in the hemato oncology testing market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global hemato oncology testing market report during the forecast period. The regions covered in the hemato oncology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10075

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.